12/12
08:06 am
gh
Guardant Health (NASDAQ:GH) had its price target raised by analysts at BTIG Research from $100.00 to $140.00. They now have a "buy" rating on the stock.
Low
Report
Guardant Health (NASDAQ:GH) had its price target raised by analysts at BTIG Research from $100.00 to $140.00. They now have a "buy" rating on the stock.
12/11
08:55 am
gh
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. [Yahoo! Finance]
Low
Report
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. [Yahoo! Finance]
12/11
08:05 am
gh
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
Low
Report
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
12/11
07:20 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
12/9
08:05 am
gh
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy
Low
Report
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy
12/8
08:00 am
gh
Hammerspace Helps Launch the Single Namespace Working Group (SNS) to End Data Fragmentation and Expose a Single, Unified Intelligence Layer for Data
Low
Report
Hammerspace Helps Launch the Single Namespace Working Group (SNS) to End Data Fragmentation and Expose a Single, Unified Intelligence Layer for Data
12/6
09:21 pm
gh
Why Guardant Health (GH) Is Down 5.9% After Big Q3 Beat And Major Capital Raise – And What's Next [Yahoo! Finance]
Low
Report
Why Guardant Health (GH) Is Down 5.9% After Big Q3 Beat And Major Capital Raise – And What's Next [Yahoo! Finance]
12/5
08:40 am
gh
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Medium
Report
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
12/5
08:05 am
gh
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium
Medium
Report
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium
12/3
03:47 pm
gh
Why Guardant Health (GH) Stock Is Up Today [Yahoo! Finance]
Low
Report
Why Guardant Health (GH) Stock Is Up Today [Yahoo! Finance]
12/1
06:03 pm
gh
Guardant Health (NASDAQ:GH) was given a new $130.00 price target on by analysts at Morgan Stanley.
Low
Report
Guardant Health (NASDAQ:GH) was given a new $130.00 price target on by analysts at Morgan Stanley.
11/25
09:36 pm
gh
Guardant Health (GH): Valuation in Focus After Obamacare Subsidy Extension Proposal Spurs Stock Surge [Yahoo! Finance]
Low
Report
Guardant Health (GH): Valuation in Focus After Obamacare Subsidy Extension Proposal Spurs Stock Surge [Yahoo! Finance]
11/20
01:16 pm
gh
The marketing guru who helped turn Khosla Ventures into an AI powerhouse is moving on [TechCrunch]
Medium
Report
The marketing guru who helped turn Khosla Ventures into an AI powerhouse is moving on [TechCrunch]
11/18
09:22 am
gh
Pellera Technologies Joins Guardant Health and Industry Leaders in Single Namespace Working Group to Transform Global Data Access [Yahoo! Finance]
Low
Report
Pellera Technologies Joins Guardant Health and Industry Leaders in Single Namespace Working Group to Transform Global Data Access [Yahoo! Finance]
11/18
07:58 am
gh
Panzura Advances Exabyte-Scale Data Access and Interoperability as Member of Single Namespace Working Group (SNS)
Low
Report
Panzura Advances Exabyte-Scale Data Access and Interoperability as Member of Single Namespace Working Group (SNS)
11/15
10:41 pm
gh
Is Guardant Health's (GH) Push for Open Data Standards Reshaping Its Sector Leadership and Growth Prospects? [Yahoo! Finance]
Low
Report
Is Guardant Health's (GH) Push for Open Data Standards Reshaping Its Sector Leadership and Growth Prospects? [Yahoo! Finance]
11/15
07:47 am
gh
Exact Sciences Corporation (EXAS) Presents at 7th Annual Healthcare Symposium Transcript [Seeking Alpha]
Low
Report
Exact Sciences Corporation (EXAS) Presents at 7th Annual Healthcare Symposium Transcript [Seeking Alpha]
11/14
01:12 pm
gh
Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript [Seeking Alpha]
Low
Report
Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript [Seeking Alpha]
11/12
08:05 am
gh
Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access
Low
Report
Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access
11/10
08:16 am
gh
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring [Yahoo! Finance]
Low
Report
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring [Yahoo! Finance]
11/10
08:05 am
gh
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
Low
Report
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
11/8
01:33 pm
gh
Guardant Health (GH): Assessing Valuation Following Expanded Equity and Convertible Capital Raises [Yahoo! Finance]
Low
Report
Guardant Health (GH): Assessing Valuation Following Expanded Equity and Convertible Capital Raises [Yahoo! Finance]
11/7
08:00 am
gh
Guardant Health to Participate in Upcoming Investor Conferences
Low
Report
Guardant Health to Participate in Upcoming Investor Conferences
11/6
06:35 pm
gh
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/6
08:05 am
gh
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
Low
Report
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response